🇺🇸 FDA
Patent

US 9856279

Therapeutically active compositions and their methods of use

granted A61KA61K31/496A61K31/498

Quick answer

US patent 9856279 (Therapeutically active compositions and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/496, A61K31/498, A61K31/4985, A61K31/501